Biosimilar Newsletter Archive

  1. 10.03.17 -- The Manufacturing Risk Biosimilar Companies Can't Afford To Ignore
    10/3/2017
    10/03/17 Biosimilar Development Newsletter
  2. 09.28.17 -- The State Of Global Biosimilar Risk Management Programs
    9/28/2017
    09/28/17 Biosimilar Development Newsletter
  3. 09.21.17 -- Unpacking Russia's Biosimilar Regulatory Pathway
    9/21/2017
    09/21/17 Biosimilar Development Newsletter
  4. 09.14.17 -- Russia's Biosimilar Market At A Glance
    9/14/2017
    09/14/17 Biosimilar Development Newsletter
  5. 09.12.17 -- Lab-Scale Bioprocessing: Perfusion or Batch?
    9/12/2017
    09/12/17 Biosimilar Development Newsletter
  6. 09.07.17 -- Plant-Based Biosimilar Development Takes Root In Brazil
    9/7/2017
    09/07/17 Biosimilar Development Newsletter
  7. 08.31.17 -- Are You Prepared For The Biosimilar Pipeline Boom?
    8/31/2017
    08/31/17 Biosimilar Development Newsletter
  8. 08.24.17 -- Building Thailand's Biosimilar Industry From The Ground Up
    8/24/2017
    08/24/17 Biosimilar Development Newsletter
  9. 08.17.17 -- Unpacking Thai FDA's Biosimilar Guidelines
    8/17/2017
    08/17/17 Biosimilar Development Newsletter
  10. 08.10.17 -- Brazil's Biosimilar PDPs: What To Know
    8/10/2017
    08/10/17 Biosimilar Development Newsletter